NEI-VFQ revealed a significant reduction in vision-related quality of life in patients suffering from SCA-ATXN1, SCA-ATXN3, or SCA-CACNA1A. The gene discussed is ATXN3; the disease is autosomal dominant cerebellar ataxia.